These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25354171)

  • 1. A Preliminary Observation of Increased Glial Cell Line-Derived Neurotrophic Factor in Manic Switch due to Electroconvulsive Treatment in Depressive Patients.
    Tunca Z; Bayn M; Alkn T; Özerdem A; Resmi H; Akan P
    J ECT; 2015 Sep; 31(3):167-72. PubMed ID: 25354171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in BDNF (brain derived neurotrophic factor) and GDNF (glial cell line-derived neurotrophic factor) serum levels in bipolar disorder: The role of lithium.
    Tunca Z; Ozerdem A; Ceylan D; Yalçın Y; Can G; Resmi H; Akan P; Ergör G; Aydemir O; Cengisiz C; Kerim D
    J Affect Disord; 2014 Sep; 166():193-200. PubMed ID: 25012431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression.
    Zhang X; Zhang Z; Sha W; Xie C; Xi G; Zhou H; Zhang Y
    Psychiatry Res; 2009 Dec; 170(2-3):273-5. PubMed ID: 19896212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse glial cell line-derived neurotrophic factor (GDNF) support between mania and schizophrenia: a comparative study in four major psychiatric disorders.
    Tunca Z; Kıvırcık Akdede B; Özerdem A; Alkın T; Polat S; Ceylan D; Bayın M; Cengizçetin Kocuk N; Şimşek S; Resmi H; Akan P
    Eur Psychiatry; 2015 Feb; 30(2):198-204. PubMed ID: 25543333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder.
    Rosa AR; Frey BN; Andreazza AC; Ceresér KM; Cunha AB; Quevedo J; Santin A; Gottfried C; Gonçalves CA; Vieta E; Kapczinski F
    Neurosci Lett; 2006 Oct; 407(2):146-50. PubMed ID: 16959421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls.
    Karamustafalioglu N; Genc A; Kalelioglu T; Tasdemir A; Umut G; Incir S; Akkuş M; Emul M
    J Psychopharmacol; 2015 Aug; 29(8):898-902. PubMed ID: 25827643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of GDNF in bipolar disorder.
    Barbosa IG; Huguet RB; Sousa LP; Abreu MN; Rocha NP; Bauer ME; Carvalho LA; Teixeira AL
    Neurosci Lett; 2011 Sep; 502(2):103-6. PubMed ID: 21820487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF) in predicting treatment remission in a Chinese Han population with generalized anxiety disorder.
    Shen Z; Zhu J; Yuan Y; Ren L; Qian M; Lin M; Cai M; Zhang Z; Shen X
    Psychiatry Res; 2019 Jan; 271():319-324. PubMed ID: 30529313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression.
    Bouckaert F; Dols A; Emsell L; De Winter FL; Vansteelandt K; Claes L; Sunaert S; Stek M; Sienaert P; Vandenbulcke M
    Neuropsychopharmacology; 2016 Oct; 41(11):2741-8. PubMed ID: 27272769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repetitive enhancement of serum BDNF subsequent to continuation ECT.
    Vanicek T; Kranz GS; Vyssoki B; Komorowski A; Fugger G; Höflich A; Micskei Z; Milovic S; Lanzenberger R; Eckert A; Kasper S; Frey R
    Acta Psychiatr Scand; 2019 Nov; 140(5):426-434. PubMed ID: 31369144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial.
    Kargar M; Yoosefi A; Akhondzadeh S; Artonian V; Ashouri A; Ghaeli P
    Pharmacopsychiatry; 2015 Nov; 48(7):268-73. PubMed ID: 26398281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.
    Fernandes B; Gama CS; Massuda R; Torres M; Camargo D; Kunz M; Belmonte-de-Abreu PS; Kapczinski F; de Almeida Fleck MP; Inês Lobato M
    Neurosci Lett; 2009 Apr; 453(3):195-8. PubMed ID: 19429034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study.
    Okamoto T; Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Inoue Y; Ueda N; Nakamura J
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1185-90. PubMed ID: 18403081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the novel seizure quality index for the outcome prediction in electroconvulsive therapy and brain-derived neurotrophic factor serum levels.
    Kranaster L; Hellweg R; Sartorius A
    Neurosci Lett; 2019 Jun; 704():164-168. PubMed ID: 30978454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features.
    Perugi G; Medda P; Toni C; Mariani MG; Socci C; Mauri M
    Curr Neuropharmacol; 2017 Apr; 15(3):359-371. PubMed ID: 28503107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF).
    Freire TF; Fleck MP; da Rocha NS
    Brain Res Bull; 2016 Mar; 121():263-9. PubMed ID: 26892396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters.
    Skibinska M; Kapelski P; Pawlak J; Rajewska-Rager A; Dmitrzak-Weglarz M; Szczepankiewicz A; Czerski P; Twarowska-Hauser J
    Psychiatry Res; 2017 Oct; 256():396-402. PubMed ID: 28689143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression.
    Marano CM; Phatak P; Vemulapalli UR; Sasan A; Nalbandyan MR; Ramanujam S; Soekadar S; Demosthenous M; Regenold WT
    J Clin Psychiatry; 2007 Apr; 68(4):512-7. PubMed ID: 17474805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy.
    Medda P; Mauri M; Fratta S; Ciaponi B; Miniati M; Toni C; Dell'Osso L; Perugi G
    J ECT; 2013 Sep; 29(3):179-88. PubMed ID: 23899721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study.
    Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV
    J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.